| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | TANG KEVIN | 10%+ owner | Buy | 48,211 | $2.42 | $117K |
| 2026-07-10 | TANG KEVIN | 10%+ owner | Buy | 43,367 | $2.43 | $105K |
| 2026-07-09 | TANG KEVIN | 10%+ owner | Buy | 7 | $2.48 | $17 |
| 2026-07-02 | TANG KEVIN | 10%+ owner | Buy | 9,821 | $2.49 | $24K |
| 2026-07-01 | TANG KEVIN | 10%+ owner | Buy | 71,612 | $2.49 | $178K |
| 2026-06-30 | TANG KEVIN | 10%+ owner | Buy | 25,930 | $2.54 | $66K |
| 2026-06-30 | TANG KEVIN | 10%+ owner | Buy | 100 | $2.50 | $250 |
| 2026-06-29 | TANG KEVIN | 10%+ owner | Buy | 63,985 | $2.47 | $158K |
| 2026-06-29 | TANG KEVIN | 10%+ owner | Buy | 777 | $2.48 | $2K |
| 2026-06-26 | TANG KEVIN | 10%+ owner | Buy | 75,047 | $2.55 | $191K |
| 2026-06-26 | TANG KEVIN | 10%+ owner | Buy | 134 | $2.54 | $340 |
| 2026-06-25 | TANG KEVIN | 10%+ owner | Buy | 145,880 | $2.48 | $362K |
| 2026-06-25 | TANG KEVIN | 10%+ owner | Buy | 510 | $2.56 | $1K |
| 2026-06-15 | Whiting Nancy | director | Award | 32,000 | $1.40 | $45K |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-27 | SCHEDULE 13D/A | Nano Dimension Ltd. | — | 16,715,812 | view → |
| 2026-06-30 | SCHEDULE 13D | Nano Dimension Ltd. NNDM | — | 14,292,813 | view → |
| 2026-06-10 | SCHEDULE 13G | Fulcrum Therapeutics, Inc. FULC | — | — | view → |
| 2026-06-04 | SCHEDULE 13D/A | Aurinia Pharmaceuticals Inc. AUPH | 10.00% | 13,044,106 | view → |
| 2026-05-13 | SCHEDULE 13D/A | Kezar Life Sciences, Inc. | — | 0 | view → |
| 2025-09-03 | SCHEDULE | iTeos Therapeutics, Inc. | 100.00% | 10,000 | view → |
| 2025-05-19 | SCHEDULE | Allakos Inc. | 100.00% | 10,000 | view → |
| 2025-04-03 | SCHEDULE | Allakos Inc. | 9.60% | 8,693,687 | view → |
| 2025-03-04 | SCHEDULE | Aurinia Pharmaceuticals Inc. AUPH | 7.30% | 10,029,500 | view → |
| 2025-02-27 | SCHEDULE | ACELYRIN, Inc. | 7.30% | 7,298,328 | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →